AlphaGrep UK Ltd’s Globus Medical GMED Stock Holding History

AlphaGrep UK Ltd’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,330	Closed	-$203K	–	842
2025 Q4	$203K	Buy	+2,330	New	+$177K	0.07%	620

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK Ltd's GMED Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 2,330 shares — an estimated $203K sold.

AlphaGrep UK Ltd first reported a position in GMED in Q4 2025 and held it in 1 quarter. The position peaked at $203K in Q4 2025. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

AlphaGrep UK Ltd reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 2,330 Globus Medical shares in Q1 2026, an estimated $203K.
AlphaGrep UK Ltd first reported a position in Globus Medical in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's Globus Medical position peaked at $203K in Q4 2025.
605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.